ACLS Provider: Course

Incorrect. Adenosine is administered as a 0.1 mg/kg rapid IV push for pediatric SVT, followed by a saline flush.

Incorrect. Early defibrillation is critical for survival, especially in shockable rhythms like VF/VT.

Incorrect. The target oxygen saturation is 92-96% to avoid hyperoxia, which can contribute to oxidative injury.

Incorrect. Atropine at 0.5 mg IV is the first-line treatment for symptomatic bradycardia caused by vagal stimulation.

Incorrect. VF is a shockable rhythm requiring immediate defibrillation to restore organized electrical activity.

Incorrect. Epinephrine is administered to increase coronary and cerebral perfusion pressure during cardiac arrest.

Incorrect. Delivering 1 breath every 5-6 seconds prevents hypoventilation or hyperventilation.

Incorrect. The compression-to-ventilation ratio for single-rescuer infant CPR is 30:2, ensuring sufficient oxygenation and circulation.

Incorrect. Asystole is a non-shockable rhythm requiring immediate CPR and epinephrine administration.

Incorrect. Oxygen levels should be monitored and optimized to maintain saturation within the target range of 92-96%.

Incorrect. Rhythm checks should be performed every 2 minutes, coinciding with rescuer role switches, to evaluate for shockable rhythms.

Incorrect. PEA is treated with epinephrine and high-quality CPR to address underlying reversible causes.

Incorrect. The maximum dose of atropine for bradycardia is 3 mg, with doses given at 0.5 mg intervals every 3-5 minutes.

Incorrect. Vagal maneuvers stimulate the vagus nerve, often terminating narrow-complex SVT caused by reentrant circuits.

Incorrect. First-line treatment to block vagal stimulation and increase heart rate.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and should be treated with warming measures.

Incorrect. Switching compressors every 2 minutes reduces rescuer fatigue, ensuring high-quality chest compressions are maintained.

Incorrect. Pulseless VT is treated with defibrillation, not atropine. Atropine is used for symptomatic bradycardia.

Incorrect. Adenosine is administered as a rapid IV push to terminate SVT in pediatric patients, followed by a saline flush.

Incorrect. Magnesium sulfate stabilizes the myocardium and is the drug of choice for torsades de pointes.

Incorrect. Positioning the patient with a slight left tilt prevents aortocaval compression and improves venous return during CPR.

Incorrect. Atropine is given at a dose of 0.5 mg every 3-5 minutes during bradycardia, up to a maximum dose of 3 mg.

Incorrect. Ventilation with an advanced airway should be provided at a rate of 1 breath every 6 seconds, or 10 breaths per minute.

Incorrect. With an advanced airway, compressions continue uninterrupted while ventilation is provided at a rate of 10 breaths per minute.

Incorrect. Naloxone is used to reverse opioid overdose, restoring respiratory effort in patients with respiratory depression.

Incorrect. TTM prevents further neurological injury by maintaining a controlled core temperature after ROSC.

Incorrect. The compression fraction should be greater than 80% to maximize perfusion during CPR.

Incorrect. Epinephrine is dosed at 0.01 mg/kg IV/IO during pediatric cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Naloxone is only used in cases of suspected opioid overdose and is not universally administered in cardiac arrest.

Incorrect. Pediatric defibrillation begins at 2 J/kg for the first shock and increases as necessary for subsequent shocks.

Incorrect. Epinephrine is given first in VF during cardiac arrest, followed by amiodarone as an antiarrhythmic after defibrillation attempts.

Incorrect. IM epinephrine is the first-line treatment for anaphylaxis, administered into the mid-thigh for rapid absorption.

Incorrect. TTM helps reduce neurological injury by maintaining a core temperature of 32-36°C after the return of spontaneous circulation.

Incorrect. Synchronized cardioversion at 100 J is effective for restoring a stable rhythm in unstable ventricular tachycardia.

Incorrect. Hypovolemia is a reversible cause of cardiac arrest that can be treated with fluid resuscitation to restore circulation.

Incorrect. Epinephrine is given as a continuous infusion to maintain adequate heart rate and perfusion when atropine is ineffective.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and is treated by warming the patient to improve outcomes.

Incorrect. Calcium gluconate stabilizes the cardiac membrane and reduces the risk of life-threatening arrhythmias caused by hyperkalemia.

Incorrect. Defibrillation attempts should be separated by 2-minute CPR cycles to ensure effective perfusion and rhythm evaluation.

Incorrect. Waveform capnography ensures proper ET tube placement by monitoring exhaled CO? levels.

Incorrect. Post-ROSC care focuses on optimizing oxygenation, ventilation, and hemodynamic stability to prevent further organ damage.

Incorrect. Oxygen saturation should be maintained at 92-96% to avoid hypoxia and reduce the risk of hyperoxia and oxidative stress.

Incorrect. Pediatric defibrillation starts at 2 J/kg and may increase to 4 J/kg for subsequent shocks if VF persists.

Incorrect. Immediate defibrillation is critical for shockable rhythms like ventricular fibrillation and pulseless VT.

Incorrect. Interruptions in chest compressions should not exceed 10 seconds to maintain adequate perfusion to vital organs.

Incorrect. A 30:2 ratio ensures adequate oxygenation and circulation when no advanced airway is present.

Incorrect. The correct dose of epinephrine for pediatric cardiac arrest is 0.01 mg/kg IV/IO, not 1 mg/kg.

Incorrect. Hypovolemia is a reversible cause of cardiac arrest and should be corrected with fluid resuscitation.

Incorrect. Prompt defibrillation within 30 seconds of witnessed VF arrest improves the chance of restoring a perfusing rhythm.

Incorrect. The same compression rate as adults ensures adequate perfusion in pediatric patients during CPR.

Incorrect. Indicates effective chest compressions and blood circulation during resuscitation.

Incorrect. A sudden increase in PETCO2 is a reliable indicator of ROSC, reflecting improved circulation and gas exchange.

Incorrect. PETCO2 monitoring provides continuous feedback on the quality of chest compressions and the effectiveness of resuscitation.

Incorrect. Adenosine is administered as a rapid IV push at an initial dose of 6 mg to terminate stable SVT.

Incorrect. Epinephrine is administered every 3-5 minutes during cardiac arrest to maximize coronary and cerebral perfusion.

Incorrect. Adenosine is administered at 0.1 mg/kg as a rapid IV push for terminating narrow-complex SVT caused by reentrant pathways.

Incorrect. PETCO2 >10 mmHg during CPR indicates effective chest compressions generating sufficient circulation.

Incorrect. Symptomatic second-degree AV block type II can progress to complete heart block, requiring pacing.

Incorrect. High-quality CPR is the primary intervention for PEA, followed by epinephrine administration and addressing reversible causes.

Incorrect. Epinephrine at 0.01 mg/kg IV/IO is administered every 3-5 minutes to enhance coronary and cerebral perfusion in children.

Incorrect. Targeted temperature management improves neurological outcomes by preventing further brain injury.

Incorrect. The 15:2 ratio improves oxygenation and circulation during high-quality infant CPR performed by two rescuers.

Incorrect. Epinephrine at 0.01 mg/kg is administered every 3-5 minutes during pediatric cardiac arrest to improve coronary perfusion.

Incorrect. Synchronized cardioversion with 50-100 J is effective for narrow, regular tachycardias that are unstable.

Incorrect. Oxygenation and ventilation should be optimized to avoid hypoxia or hyperoxia during post-cardiac arrest care.